Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9012615 | Life Sciences | 2005 | 5 Pages |
Abstract
Autologous transplant of bone marrow stem cells (BMSC), although extremely useful after acute myocardial events, has not been evaluated in patients with old (>Â one-year-old) myocardial infarction. Our aim was to determine if CD34+-enriched peripheral-blood cells, obtained by apheresis, injected directly into the severely damaged myocardium of five patients with old myocardial infarction could restore depressed myocardial function. We found that 28 weeks after revascularization and peri-infarction injection of the enriched CD34+ peripheral mononuclear cells, ventricular hemodynamic parameters that included left ventricular ejection fraction, left ventricular diastolic volume, ventricular systolic volume and left ventricular diastolic diameter approximated normal values and there was no restenosis; two patients have been followed for >Â 52 weeks and their parameters are within normal values. In conclusion, intramyocardial injection of easily obtained CD34+ enriched peripheral blood cells represent an encouraging procedure for patients with severely scarred and dysfunctional myocardium.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Abel Archundia, José Luis Aceves, Manuel López-Hernández, Martha Alvarado, Emma Rodriguez, Guillermo DÃaz Quiroz, Araceli Páez, Felipe Masso Rojas, Luis Felipe Montaño,